• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

NAMAPA Launches Medication Access Network to Help Patients on Their Access Journeys


Charlotte, North Carolina, February 21, 2023—The National Association of Medication Access and Patient Advocacy (NAMAPA) has announced today the launch of its newest access advocate network, the Medication Access Network. The network brings together healthcare advocates throughout the country to assist patients who need help navigating through the medication access journey. Gaining access to medication is cumbersome process and difficult for healthcare provider; it can be even more daunting for patients. This program provides patients with an experienced advocate, at no cost, to help them understand the process and answer any questions they may have.

Positive customer impact
Patients have already experienced positive outcomes working with their Medication Access Advocate when it comes to obtaining access to their prescribed medications at an affordable cost. Although prescribers and advocates in provider offices deal with access issues daily, sometimes patient involvement is needed to demonstrate to the insurance companies that a prescribed treatment is both medically necessary and necessary for their quality of life. Additionally, there are times when an insurer requires explanation and documentation from both the provider's office and the patient. This is one of the many areas where the Medication Access Network can provide assistance to patients by giving them advice, guidance and a voice, alongside their providers, in providing access to prescribed therapies at an affordable cost.

Read more here.

Related Content
© 2024 MJH Life Sciences

All rights reserved.